Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Recent advances in the management of peptic ulcer bleeding.

Beales I.

F1000Res. 2017 Sep 27;6:1763. doi: 10.12688/f1000research.11286.1. eCollection 2017. Review.

2.

Upper gastrointestinal haemorrhage: an update.

Jafar W, Jafar AJN, Sharma A.

Frontline Gastroenterol. 2016 Jan;7(1):32-40. doi: 10.1136/flgastro-2014-100492. Epub 2014 Oct 10. Review.

3.

Aspirin for primary prevention of cardiovascular disease.

Nansseu JR, Noubiap JJ.

Thromb J. 2015 Dec 4;13:38. doi: 10.1186/s12959-015-0068-7. eCollection 2015. Review.

4.

Diagnosis and therapy of non-variceal upper gastrointestinal bleeding.

Biecker E.

World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):172-82. doi: 10.4292/wjgpt.v6.i4.172. Review.

5.

Consensus on control of risky nonvariceal upper gastrointestinal bleeding in Taiwan with National Health Insurance.

Sheu BS, Wu CY, Wu MS, Chiu CT, Lin CC, Hsu PI, Cheng HC, Lee TY, Wang HP, Lin JT.

Biomed Res Int. 2014;2014:563707. doi: 10.1155/2014/563707. Epub 2014 Aug 14.

6.

The role of aspirin in the prevention of cardiovascular disease.

Ittaman SV, VanWormer JJ, Rezkalla SH.

Clin Med Res. 2014 Dec;12(3-4):147-54. doi: 10.3121/cmr.2013.1197. Epub 2014 Feb 26. Review.

7.

Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole.

Tang RS, Wu JC.

Clin Interv Aging. 2013;8:1433-43. doi: 10.2147/CIA.S41350. Epub 2013 Oct 25. Review.

8.

Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance.

Brooks J, Warburton R, Beales IL.

Ther Adv Chronic Dis. 2013 Sep;4(5):206-22. doi: 10.1177/2040622313492188.

9.

Clopidogrel versus Other Antiplatelet Agents in the Secondary Prevention of Vascular Events in Adults with Cerebrovascular Disease: Clinical and Cost-Effectiveness Analyses.

Canadian Agency for Drugs and Technologies in Health (CADTH).

CADTH Technol Overv. 2010;1(3):e0121. Epub 2010 Sep 1. No abstract available.

10.
11.

Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases.

Gurbel PA, Tantry US, Kereiakes DJ.

Drug Healthc Patient Saf. 2010;2:233-40. doi: 10.2147/DHPS.S7297. Epub 2010 Nov 15.

12.

Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin.

Vonkeman H, Meek I, van de Laar M.

Drug Healthc Patient Saf. 2010;2:191-204. doi: 10.2147/DHPS.S7206. Epub 2010 Oct 6.

13.

Recent advances in peptic ulcer bleeding.

Beales IL.

F1000 Med Rep. 2009 May 28;1. pii: 44. doi: 10.3410/M1-44.

14.

Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction.

Vachhani R, Bouhaidar D, Zfass A, Sandhu B, Nawras A.

Ther Clin Risk Manag. 2010 Jun 24;6:287-92.

15.

Modern role for clopidogrel in management of atrial fibrillation and stroke reduction.

Maegdefessel L, Azuma J, Tsao PS.

Vasc Health Risk Manag. 2010 Mar 3;6:95-103. Review.

16.

Myocardial infarction, peptic ulcer and acetylsalicylic acid: of good and evil.

Marshall JK.

Can J Gastroenterol. 2009 Sep;23(9):618. No abstract available.

Supplemental Content

Support Center